Correlation Between Catalyst Pharmaceuticals and Skechers USA
Can any of the company-specific risk be diversified away by investing in both Catalyst Pharmaceuticals and Skechers USA at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Catalyst Pharmaceuticals and Skechers USA into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Catalyst Pharmaceuticals and Skechers USA, you can compare the effects of market volatilities on Catalyst Pharmaceuticals and Skechers USA and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Catalyst Pharmaceuticals with a short position of Skechers USA. Check out your portfolio center. Please also check ongoing floating volatility patterns of Catalyst Pharmaceuticals and Skechers USA.
Diversification Opportunities for Catalyst Pharmaceuticals and Skechers USA
0.0 | Correlation Coefficient |
Pay attention - limited upside
The 3 months correlation between Catalyst and Skechers is 0.0. Overlapping area represents the amount of risk that can be diversified away by holding Catalyst Pharmaceuticals and Skechers USA in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Skechers USA and Catalyst Pharmaceuticals is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Catalyst Pharmaceuticals are associated (or correlated) with Skechers USA. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Skechers USA has no effect on the direction of Catalyst Pharmaceuticals i.e., Catalyst Pharmaceuticals and Skechers USA go up and down completely randomly.
Pair Corralation between Catalyst Pharmaceuticals and Skechers USA
Given the investment horizon of 90 days Catalyst Pharmaceuticals is expected to generate 4.25 times more return on investment than Skechers USA. However, Catalyst Pharmaceuticals is 4.25 times more volatile than Skechers USA. It trades about 0.1 of its potential returns per unit of risk. Skechers USA is currently generating about 0.17 per unit of risk. If you would invest 2,127 in Catalyst Pharmaceuticals on October 21, 2024 and sell it today you would earn a total of 151.00 from holding Catalyst Pharmaceuticals or generate 7.1% return on investment over 90 days.
| Time Period | 3 Months [change] |
| Direction | Flat |
| Strength | Insignificant |
| Accuracy | 100.0% |
| Values | Daily Returns |
Catalyst Pharmaceuticals vs. Skechers USA
Performance |
| Timeline |
| Catalyst Pharmaceuticals |
| Skechers USA |
Catalyst Pharmaceuticals and Skechers USA Volatility Contrast
Predicted Return Density |
| Returns |
Pair Trading with Catalyst Pharmaceuticals and Skechers USA
The main advantage of trading using opposite Catalyst Pharmaceuticals and Skechers USA positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Catalyst Pharmaceuticals position performs unexpectedly, Skechers USA can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Skechers USA will offset losses from the drop in Skechers USA's long position.| Catalyst Pharmaceuticals vs. Day One Biopharmaceuticals | Catalyst Pharmaceuticals vs. Terns Pharmaceuticals | Catalyst Pharmaceuticals vs. X4 Pharmaceuticals | Catalyst Pharmaceuticals vs. Inozyme Pharma |
| Skechers USA vs. Crocs Inc | Skechers USA vs. On Holding | Skechers USA vs. Nike Inc | Skechers USA vs. Designer Brands |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Positions Ratings module to determine portfolio positions ratings based on digital equity recommendations. Macroaxis instant position ratings are based on combination of fundamental analysis and risk-adjusted market performance.
Other Complementary Tools
| ETFs Find actively traded Exchange Traded Funds (ETF) from around the world | |
| Companies Directory Evaluate performance of over 100,000 Stocks, Funds, and ETFs against different fundamentals | |
| Portfolio Manager State of the art Portfolio Manager to monitor and improve performance of your invested capital | |
| Portfolio Suggestion Get suggestions outside of your existing asset allocation including your own model portfolios | |
| Portfolio Volatility Check portfolio volatility and analyze historical return density to properly model market risk |